Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 237

    1.

    What is the Benefit of Bevacizumab Combined with Chemotherapy in Patients with Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Malignancies?

    Cheng X, Moroney JW, Levenback CF, Fu S, Jaishuen A, Kavanagh JJ.

    J Chemother. 2009 Nov;21(5):566-72.PMID: 19933049 [PubMed - in process]

    2.

    Nuclear cyclin B1 is overexpressed in low-malignant-potential ovarian tumors but not in epithelial ovarian cancer.

    Zheng H, Hu W, Deavers MT, Shen DY, Fu S, Li YF, Kavanagh JJ.

    Am J Obstet Gynecol. 2009 Oct;201(4):367.e1-6. Epub 2009 Jul 15.PMID: 19608149 [PubMed - indexed for MEDLINE]Related articles

    3.

    Voluntary sway and rapid orthogonal transitions of voluntary sway in young adults, and low and high fall-risk older adults.

    Tucker MG, Kavanagh JJ, Morrison S, Barrett RS.

    Clin Biomech (Bristol, Avon). 2009 Oct;24(8):597-605. Epub 2009 Jun 28.PMID: 19564063 [PubMed - indexed for MEDLINE]Related articles

    4.

    Uterine Neoplasms. Clinical Practice Guidelines in Oncology.

    Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos SM, Cho KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jaggernauth W, Kapp DS, Kavanagh JJ, Lurain JR 3rd, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W Jr, Teng N.

    J Natl Compr Canc Netw. 2009 May;7(5):498-531. Review. No abstract available. PMID: 19460278 [PubMed - indexed for MEDLINE]Related articles

    5.

    Poor survival outcome with moderate and severe hypercalcemia in gynecologic malignancy patients.

    Jaishuen A, Jimenez C, Sirisabya N, Li Y, Zheng H, Hu W, Urbauer DL, Kavanagh JJ.

    Int J Gynecol Cancer. 2009 Feb;19(2):178-85.PMID: 19395991 [PubMed - indexed for MEDLINE]Related articles

    6.

    Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.

    Gershenson DM, Sun CC, Bodurka D, Coleman RL, Lu KH, Sood AK, Deavers M, Malpica AL, Kavanagh JJ.

    Gynecol Oncol. 2009 Jul;114(1):48-52. Epub 2009 Apr 10.PMID: 19361839 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lower trunk motion and speed-dependence during walking.

    Kavanagh JJ.

    J Neuroeng Rehabil. 2009 Apr 9;6:9.PMID: 19356256 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis.

    Li Y, Hu W, Shen DY, Kavanagh JJ, Fu S.

    Am J Obstet Gynecol. 2009 Feb;200(2):177.e1-9. Epub 2008 Dec 25.PMID: 19110234 [PubMed - indexed for MEDLINE]Related articles

    9.

    Update on aurora kinase inhibitors in gynecologic malignancies.

    Tao X, Chon HS, Fu S, Kavanagh JJ, Hu W.

    Recent Pat Anticancer Drug Discov. 2008 Nov;3(3):162-77. Review.PMID: 18991785 [PubMed - indexed for MEDLINE]Related articles

    10.

    Ovarian endometriosis associated with carcinoma and sarcoma: case report.

    Boruban MC, Jaishuen A, Sirisabya N, Li Y, Zheng HG, Deavers MT, Kavanagh JJ.

    Eur J Gynaecol Oncol. 2008;29(4):393-6.PMID: 18714578 [PubMed - indexed for MEDLINE]Related articles

    11.

    Chemotherapy for recurrent and metastatic cervical cancer.

    Tao X, Hu W, Ramirez PT, Kavanagh JJ.

    Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S67-71. Epub 2008 Jun 3. Review.PMID: 18533239 [PubMed - indexed for MEDLINE]Related articles

    12.

    Age-related differences in postural reaction time and coordination during voluntary sway movements.

    Tucker MG, Kavanagh JJ, Barrett RS, Morrison S.

    Hum Mov Sci. 2008 Oct;27(5):728-37. Epub 2008 May 29.PMID: 18513814 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diammine dicarboxylic acid platinum enhances cytotoxicity in platinum-resistant ovarian cancer cells through induction of apoptosis and S-phase cell arrest.

    Zheng H, Hu W, Yu D, Shen DY, Fu S, Kavanagh JJ, Wei IC, Yang DJ.

    Pharm Res. 2008 Oct;25(10):2272-82. Epub 2008 May 29.PMID: 18509599 [PubMed - indexed for MEDLINE]Related articles

    14.

    Chemotherapy for gynecological malignancies in organ transplantation patients: report of two cases.

    Tao X, Kavanagh JJ.

    Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1376-80. Epub 2008 May 6.PMID: 18462370 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum.

    Ramirez PT, Schmeler KM, Milam MR, Slomovitz BM, Smith JA, Kavanagh JJ, Deavers M, Levenback C, Coleman RL, Gershenson DM.

    Gynecol Oncol. 2008 Jul;110(1):56-9. Epub 2008 May 5.PMID: 18457865 [PubMed - indexed for MEDLINE]Related articles

    16.

    Accelerometry: a technique for quantifying movement patterns during walking.

    Kavanagh JJ, Menz HB.

    Gait Posture. 2008 Jul;28(1):1-15. Epub 2008 Feb 21. Review.PMID: 18178436 [PubMed - indexed for MEDLINE]Related articles

    17.

    One cannot be too careful while reprinting the formulae estimating creatinine clearance to avoid serious subsequent mistake.

    Li Y, Kavanagh JJ.

    Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1151. Epub 2007 Nov 16. No abstract available. PMID: 18021212 [PubMed - indexed for MEDLINE]Related articles

    18.

    Aromatase inhibitors in ovarian cancer: is there a role?

    Li YF, Hu W, Fu SQ, Li JD, Liu JH, Kavanagh JJ.

    Int J Gynecol Cancer. 2008 Jul-Aug;18(4):600-14. Epub 2007 Sep 25. Review.PMID: 17894799 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction.

    Sirisabya N, Li Y, Jaishuen A, Zheng HG, Gershenson DM, Kavanagh JJ.

    Int J Gynecol Cancer. 2008 Jul-Aug;18(4):648-51. Epub 2007 Sep 24.PMID: 17892459 [PubMed - indexed for MEDLINE]Related articles

    20.

    Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

    Kavanagh JJ, Sill MW, Ramirez PT, Warshal D, Pearl ML, Morgan MA.

    Int J Gynecol Cancer. 2008 May-Jun;18(3):460-4. Epub 2007 Sep 13.PMID: 17854432 [PubMed - indexed for MEDLINE]Related articles

    21.

    Hormone replacement therapy after treatment of endometrial cancer.

    Tangjitgamol S, Manusirivithaya S, Hanprasertpong J, Kavanagh JJ.

    Gynecol Obstet Invest. 2008;65(1):35-8. Epub 2008 Jan 15. Review.PMID: 17687189 [PubMed - indexed for MEDLINE]Related articles

    22.

    Intraperitoneal chemotherapy in the treatment of ovarian cancer.

    Kavanagh JJ.

    J Surg Oncol. 2007 Dec 1;96(7):541-2. No abstract available. PMID: 17654524 [PubMed - indexed for MEDLINE]Related articles

    23.

    Erosive osteoarthritis during treatment with bevacizumab and paclitaxel in a patient with recurrent papillary serous carcinoma of the ovary.

    Jaishuen A, Berrios-Rivera JP, Sirisabya N, Zheng HG, Li Y, Kavanagh JJ.

    Int J Gynecol Cancer. 2008 Mar-Apr;18(2):379-83. Epub 2007 Jul 11.PMID: 17624988 [PubMed - indexed for MEDLINE]Related articles

    24.

    Pegylated liposomal doxorubicin treatment in recurrent gynecologic cancer patients with renal dysfunction.

    Li Y, Finkel KW, Hu W, Fu S, Liu J, Coleman R, Kavanagh JJ.

    Gynecol Oncol. 2007 Aug;106(2):375-80. Epub 2007 May 18.PMID: 17512575 [PubMed - indexed for MEDLINE]Related articles

    25.

    Hormonal therapy in ovarian cancer.

    Zheng H, Kavanagh JJ, Hu W, Liao Q, Fu S.

    Int J Gynecol Cancer. 2007 Mar-Apr;17(2):325-38. Review.PMID: 17362310 [PubMed - indexed for MEDLINE]Related articles

    26.

    Systemic anticancer therapy in gynecological cancer patients with renal dysfunction.

    Li YF, Fu S, Hu W, Liu JH, Finkel KW, Gershenson DM, Kavanagh JJ.

    Int J Gynecol Cancer. 2007 Jul-Aug;17(4):739-63. Epub 2007 Feb 16. Review.PMID: 17309673 [PubMed - indexed for MEDLINE]Related articles

    27.

    Clinical application of oxaliplatin in epithelial ovarian cancer.

    Fu S, Kavanagh JJ, Hu W, Bast RC Jr.

    Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1717-32. Review.PMID: 17009963 [PubMed - indexed for MEDLINE]Related articles

    28.

    Immunobiology of gestational trophoblastic diseases.

    Wang X, Fu S, Freedman RS, Liu J, Kavanagh JJ.

    Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1500-15. Review.PMID: 16884358 [PubMed - indexed for MEDLINE]Related articles

    29.

    Targeted therapies in gynecologic cancers.

    Chon HS, Hu W, Kavanagh JJ.

    Curr Cancer Drug Targets. 2006 Jun;6(4):333-63. Review.PMID: 16848724 [PubMed - indexed for MEDLINE]Related articles

    30.

    Lumbar and cervical erector spinae fatigue elicit compensatory postural responses to assist in maintaining head stability during walking.

    Kavanagh JJ, Morrison S, Barrett RS.

    J Appl Physiol. 2006 Oct;101(4):1118-26. Epub 2006 Jun 8.PMID: 16763109 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Calyceal diverticulum mimicking a renal tumor on FDG PET imaging.

    Kavanagh JJ, Gordon L, Curry NS, Ravenel JG.

    Clin Nucl Med. 2006 May;31(5):301-2. No abstract available. PMID: 16622345 [PubMed - indexed for MEDLINE]Related articles

    32.

    Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.

    Rosen DG, Yang G, Deavers MT, Malpica A, Kavanagh JJ, Mills GB, Liu J.

    Cancer. 2006 May 1;106(9):1925-32.PMID: 16568440 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Venous thromboembolism syndrome in gynecological cancer.

    Wang X, Fu S, Freedman RS, Kavanagh JJ.

    Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:458-71. Review.PMID: 16515646 [PubMed - indexed for MEDLINE]Related articles

    34.

    Metastasis to sigmoid colon mucosa and submucosa from serous borderline ovarian tumor: response to hormone therapy.

    Lee EJ, Deavers MT, Hughes JI, Lee JH, Kavanagh JJ.

    Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:295-9.PMID: 16515607 [PubMed - indexed for MEDLINE]Related articles

    35.

    Targeting Aurora kinases in ovarian cancer.

    Fu S, Hu W, Kavanagh JJ, Bast RC Jr.

    Expert Opin Ther Targets. 2006 Feb;10(1):77-85. Review.PMID: 16441230 [PubMed - indexed for MEDLINE]Related articles

    36.

    Response of recurrent uterine high-grade malignant mixed müllerian tumor to letrozole.

    Wang X, Tangjitgamol S, Liu J, Kavanagh JJ.

    Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1243-8.PMID: 16343224 [PubMed - indexed for MEDLINE]Related articles

    37.

    Benign multicystic peritoneal mesothelioma: cases reports in the family with diverticulosis and literature review.

    Tangjitgamol S, Erlichman J, Northrup H, Malpica A, Wang X, Lee E, Kavanagh JJ.

    Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1101-7. Review.PMID: 16343188 [PubMed - indexed for MEDLINE]Related articles

    38.

    Computed tomography and pulmonary embolus: a review.

    Lake DR, Kavanagh JJ, Ravenel JG, Schoepf UJ, Costello P.

    Semin Ultrasound CT MR. 2005 Oct;26(5):270-80. Review.PMID: 16273999 [PubMed - indexed for MEDLINE]Related articles

    39.

    Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

    Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM.

    Gynecol Oncol. 2006 Apr;101(1):126-31. Epub 2005 Nov 3.PMID: 16271384 [PubMed - indexed for MEDLINE]Related articles

    40.

    Ethics guidelines for research with the recently dead.

    Pentz RD, Cohen CB, Wicclair M, DeVita MA, Flamm AL, Youngner SJ, Hamric AB, McCabe MS, Glover JJ, Kittiko WJ, Kinlaw K, Keller J, Asch A, Kavanagh JJ, Arap W.

    Nat Med. 2005 Nov;11(11):1145-9.PMID: 16270065 [PubMed - indexed for MEDLINE]Related articles

    41.

    Reliability of segmental accelerations measured using a new wireless gait analysis system.

    Kavanagh JJ, Morrison S, James DA, Barrett R.

    J Biomech. 2006;39(15):2863-72. Epub 2005 Oct 25.PMID: 16253263 [PubMed - indexed for MEDLINE]Related articles

    42.

    Age-related differences in head and trunk coordination during walking.

    Kavanagh JJ, Barrett RS, Morrison S.

    Hum Mov Sci. 2005 Aug;24(4):574-87. Epub 2005 Aug 24.PMID: 16125264 [PubMed - indexed for MEDLINE]Related articles

    44.

    Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer.

    Kavanagh JJ, Gershenson DM, Choi H, Lewis L, Patel K, Brown GL, Garcia A, Spriggs DR.

    Int J Gynecol Cancer. 2005 Jul-Aug;15(4):593-600.PMID: 16014111 [PubMed - indexed for MEDLINE]Related articles

    45.

    Ovarian cancer, the coagulation pathway, and inflammation.

    Wang X, Wang E, Kavanagh JJ, Freedman RS.

    J Transl Med. 2005 Jun 21;3:25.PMID: 15969748 [PubMed]Related articlesFree article

    46.

    Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.

    Hu W, Kavanagh JJ, Deaver M, Johnston DA, Freedman RS, Verschraegen CF, Sen S.

    Oncol Res. 2005;15(1):49-57.PMID: 15839305 [PubMed - indexed for MEDLINE]Related articles

    47.

    Coordination of head and trunk accelerations during walking.

    Kavanagh JJ, Morrison S, Barrett RS.

    Eur J Appl Physiol. 2005 Jul;94(4):468-75. Epub 2005 Apr 13.PMID: 15827734 [PubMed - indexed for MEDLINE]Related articles

    48.

    Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance.

    See HT, Freedman RS, Kudelka AP, Burke TW, Gershenson DM, Tangjitgamol S, Kavanagh JJ.

    Int J Gynecol Cancer. 2005 Mar-Apr;15(2):209-16.PMID: 15823101 [PubMed - indexed for MEDLINE]Related articles

    49.

    Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.

    Alberts DS, Muggia FM, Carmichael J, Winer EP, Jahanzeb M, Venook AP, Skubitz KM, Rivera E, Sparano JA, DiBella NJ, Stewart SJ, Kavanagh JJ, Gabizon AA.

    Semin Oncol. 2004 Dec;31(6 Suppl 13):53-90. Review.PMID: 15717738 [PubMed - indexed for MEDLINE]Related articles

    50.

    Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion.

    Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemistö A, Kavanagh JJ, Lee JH, Zhang W.

    Mol Cancer. 2005 Feb 2;4(1):7.PMID: 15686601 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...